It has been reported that disruption of Keap1 in mice leads to hyperkeratosis in esophagus, forestomach, and skin, most likely because of constitutive activation of NRF2 and aberrant expression of some ARE-dependent cytokeratins (Wakabayashi et al. 2003). This evidence concerns the gene KEAP1 and Hyperkeratosis.